Merit Medical Systems (NASDAQ:MMSI) Price Target Raised to $115.00

Merit Medical Systems (NASDAQ:MMSI) had its price objective hoisted by Barrington Research from $114.00 to $115.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has an outperform rating on the medical instruments supplier’s stock. Barrington Research also issued estimates for Merit Medical Systems’ Q3 2025 earnings at $0.96 EPS, Q4 2025 earnings at $0.94 EPS, FY2025 earnings at $3.82 EPS and FY2026 earnings at $4.30 EPS.

Other analysts have also issued research reports about the company. StockNews.com lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Robert W. Baird raised their target price on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a report on Thursday, October 31st. Canaccord Genuity Group upped their price target on shares of Merit Medical Systems from $125.00 to $127.00 and gave the company a “buy” rating in a report on Monday, December 9th. Piper Sandler raised their price objective on shares of Merit Medical Systems from $110.00 to $114.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 21st. Finally, Raymond James upped their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Tuesday, December 31st. Two analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $109.80.

Merit Medical Systems Price Performance

Shares of Merit Medical Systems stock opened at $108.88 on Wednesday. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57. Merit Medical Systems has a 12 month low of $70.70 and a 12 month high of $111.45. The stock has a 50 day moving average of $101.47 and a 200 day moving average of $97.13. The firm has a market cap of $6.35 billion, a PE ratio of 53.37, a PEG ratio of 2.42 and a beta of 0.85.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.06. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The company had revenue of $339.85 million for the quarter, compared to analysts’ expectations of $334.60 million. During the same quarter in the previous year, the business posted $0.75 earnings per share. Merit Medical Systems’s quarterly revenue was up 7.8% on a year-over-year basis. On average, research analysts expect that Merit Medical Systems will post 3.37 EPS for the current fiscal year.

Insider Activity at Merit Medical Systems

In related news, CFO Raul Jr. Parra sold 29,646 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $98.02, for a total transaction of $2,905,900.92. Following the completion of the sale, the chief financial officer now owns 16,361 shares of the company’s stock, valued at $1,603,705.22. This represents a 64.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director F. Ann Millner sold 12,500 shares of Merit Medical Systems stock in a transaction on Friday, November 15th. The stock was sold at an average price of $101.55, for a total transaction of $1,269,375.00. Following the completion of the transaction, the director now directly owns 32,391 shares in the company, valued at $3,289,306.05. This represents a 27.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.70% of the stock is owned by corporate insiders.

Institutional Trading of Merit Medical Systems

A number of institutional investors have recently made changes to their positions in the business. USA Financial Formulas acquired a new stake in Merit Medical Systems in the third quarter worth about $59,000. Farther Finance Advisors LLC boosted its stake in Merit Medical Systems by 32.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares in the last quarter. Harvest Fund Management Co. Ltd purchased a new stake in Merit Medical Systems during the 3rd quarter worth approximately $120,000. GAMMA Investing LLC increased its stake in Merit Medical Systems by 56.8% during the 3rd quarter. GAMMA Investing LLC now owns 1,303 shares of the medical instruments supplier’s stock valued at $129,000 after purchasing an additional 472 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in shares of Merit Medical Systems by 13.9% in the third quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock worth $171,000 after buying an additional 211 shares during the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.